• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Inflammation (1932); Pain (1994)
Event Date 03/31/2022
Event Type  Injury  
Event Description
It was reported that the patient went to the hospital one month after the tactra implant surgery due to pain in the surgical site.As a result of the inspection, inflammation and infection were found and the device was removed.Four month after the explant procedure, when the inflammation treatment with antibiotic and anti-inflammatory medicine was completed, a surgery was performed to implant a new tactra.The cause of the inflammation was not detailed by the hospital.No further patient complications were reported.
 
Manufacturer Narrative
Upon receipt at our quality assurance laboratory, this tactra underwent a thorough analysis.The cylinders were visually and microscopically examined.No anomalies were found with the tactra.Based on the information available and analysis results, the product analysis was unable to confirm any device issue that could have caused or contributed to the reported clinical observation of inflammation, pain and infection.
 
Event Description
It was reported that the patient went to the hospital one month after the tactra implant surgery due to pain in the surgical site.As a result of the inspection, inflammation and infection were found and the device was removed.Four month after the explant procedure, when the inflammation treatment with antibiotic and anti-inflammatory medicine was completed, a surgery was performed to implant a new tactra.The cause of the inflammation was not detailed by the hospital.No further patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA MALLEABLE PENILE PROTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
alyson harris
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key15191600
MDR Text Key297514478
Report Number2124215-2022-29462
Device Sequence Number1
Product Code FAE
UDI-Device Identifier08714729979357
UDI-Public08714729979357
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K183619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0027376987
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/18/2022
Initial Date FDA Received08/09/2022
Supplement Dates Manufacturer Received08/17/2022
Supplement Dates FDA Received09/09/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
Patient SexMale
-
-